Global hemoglobinopathies market is anticipated to grow at a CAGR of 7.9% during the forecast period (2024-2031). A major factor supporting the growth of the market is the rising approvals from the regulatory bodies for novel therapies are the opportunity factor for market growth. Further, the different programs undertaken by governments, like thalassemia screening in neonates & […]
Tag Archives: Hemoglobinopathies Market
The Global Hemoglobinopathies Market size was valued at USD 7.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 10% from 2021 to 2027. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in the hemoglobin molecule, particularly defective globin chains. Hemoglobinopathy is a hereditary single-gene disease, with sickle cell […]
The Hemoglobinopathies Market size is expected to grow at an annual average of 9% during 2021-2027. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in the hemoglobin molecule, particularly defective globin chains. Hemoglobinopathy is a hereditary single-gene disease, with sickle cell disease being the most common type. The prevalence of hemoglobinopathy is high in […]
The Global Hemoglobinopathies Market size was valued at USD 7.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 10% from 2021 to 2027. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in the hemoglobin molecule, particularly defective globin chains. Hemoglobinopathy is a hereditary single-gene disease, with […]